Literature DB >> 15014618

The Diagnosis and Management of Attention-Deficit/Hyperactivity Disorder in Pediatric Patients.

Andrew R. Adesman1.   

Abstract

Attention-deficit/hyperactivity disorder (ADHD), characterized by developmentally inappropriate inattentiveness, impulsivity, and hyperactivity, is the most common and thoroughly researched neuropsychiatric disorder affecting children and adolescents. The diagnosis of ADHD requires a comprehensive clinical assessment including a detailed patient history, clinical interview and observation, and a thorough physical examination. A variety of other disorders can masquerade as ADHD or coexist with the disorder. The clinician must recognize environmental influences that may affect the severity of symptoms exhibited in the child or adolescent with ADHD. Clinically, treatment with a stimulant can be expected to result in an immediate, often dramatic, improvement in the core symptoms of ADHD. Studies published over the past 20 years indicate that the symptoms of ADHD, which were originally thought to diminish as a child matured, may persist into adolescence and adulthood. This article is a review of the most recent recommendations and clinical data regarding the diagnosis and management of ADHD in children and adolescents to assist with appropriate and prudent clinical decision making.

Entities:  

Year:  2001        PMID: 15014618      PMCID: PMC181164          DOI: 10.4088/pcc.v03n0204

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  89 in total

Review 1.  Treatment of attention-deficit-hyperactivity disorder.

Authors:  J Elia; P J Ambrosini; J L Rapoport
Journal:  N Engl J Med       Date:  1999-03-11       Impact factor: 91.245

2.  Depression of growth in hyperactive children on stimulant drugs.

Authors:  D Safer; R Allen; E Barr
Journal:  N Engl J Med       Date:  1972-08-03       Impact factor: 91.245

3.  Medication treatment strategies in the MTA Study: relevance to clinicians and researchers.

Authors:  L L Greenhill; H B Abikoff; L E Arnold; D P Cantwell; C K Conners; G Elliott; L Hechtman; S P Hinshaw; B Hoza; P S Jensen; J S March; J Newcorn; W E Pelham; J B Severe; J M Swanson; B Vitiello; K Wells
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-10       Impact factor: 8.829

4.  An epidemiological study of disorders in late childhood and adolescence--I. Age- and gender-specific prevalence.

Authors:  P Cohen; J Cohen; S Kasen; C N Velez; C Hartmark; J Johnson; M Rojas; J Brook; E L Streuning
Journal:  J Child Psychol Psychiatry       Date:  1993-09       Impact factor: 8.982

5.  Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): efficacy rate and side effects.

Authors:  P A Ahmann; F W Theye; R Berg; A J Linquist; A J Van Erem; L R Campbell
Journal:  Pediatrics       Date:  2001-01       Impact factor: 7.124

Review 6.  Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.

Authors:  L S Goldman; M Genel; R J Bezman; P J Slanetz
Journal:  JAMA       Date:  1998-04-08       Impact factor: 56.272

7.  A comparison of ritalin and adderall: efficacy and time-course in children with attention-deficit/hyperactivity disorder.

Authors:  W E Pelham; H R Aronoff; J K Midlam; C J Shapiro; E M Gnagy; A M Chronis; A N Onyango; G Forehand; A Nguyen; J Waxmonsky
Journal:  Pediatrics       Date:  1999-04       Impact factor: 7.124

8.  Attention and impulsivity characteristics of the biological and adoptive parents of hyperactive and normal control children.

Authors:  Jody Alberts-Corush; Philip Firestone; John T Goodman
Journal:  Am J Orthopsychiatry       Date:  1986-07

9.  Dextroamphetamine. Its cognitive and behavioral effects in normal and hyperactive boys and normal men.

Authors:  J L Rapoport; M S Buchsbaum; H Weingartner; T P Zahn; C Ludlow; E J Mikkelsen
Journal:  Arch Gen Psychiatry       Date:  1980-08

10.  Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds.

Authors:  D M Fergusson; L J Horwood; M T Lynskey
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1993-11       Impact factor: 8.829

View more
  13 in total

1.  Sociodemographic and economic comparisons of children prescribed longer-acting versus short-acting stimulant medications for attention deficit hyperactivity disorder.

Authors:  Jack Stevens; Jeffrey S Harman; Kelly J Kelleher
Journal:  J Behav Health Serv Res       Date:  2005 Oct-Dec       Impact factor: 1.505

Review 2.  Lisdexamfetamine Dimesylate: A Review in Paediatric ADHD.

Authors:  James E Frampton
Journal:  Drugs       Date:  2018-07       Impact factor: 9.546

3.  Combination and switching of stimulants in children and adolescents with attention deficit/hyperactivity disorder in quebec.

Authors:  Leila Ben Amor; Vanja Sikirica; Martin Cloutier; Jean Lachaine; Annie Guerin; Valerie Carter; Paul Hodgkins; Judy van Stralen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2014-09

Review 4.  The pharmacology and clinical outcomes of amphetamines to treat ADHD: does composition matter?

Authors:  Paul Hodgkins; Monica Shaw; Suzanne McCarthy; Floyd R Sallee
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

5.  Oral and intravenous caffeine for treatment of children with post-sedation paradoxical hyperactivity.

Authors:  Joan T Rubin; Richard B Towbin; MaryBeth Bartko; Kevin M Baskin; Anne Marie Cahill; Robin D Kaye
Journal:  Pediatr Radiol       Date:  2004-09-08

6.  Prevalence and determinants of attention deficit/hyperactivity disorder (ADHD) medication use during pregnancy: Results from the Quebec Pregnancy/Children Cohort.

Authors:  Maxim Lemelin; Takoua Boukhris; Jin-Ping Zhao; Odile Sheehy; Anick Bérard
Journal:  Pharmacol Res Perspect       Date:  2021-05

7.  Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine.

Authors:  Hideyuki Imagawa; Saurabh P Nagar; William Montgomery; Tomomi Nakamura; Masayo Sato; Keith L Davis
Journal:  Neuropsychiatr Dis Treat       Date:  2018-02-22       Impact factor: 2.570

8.  The maternal prepregnancy body mass index and the risk of attention deficit hyperactivity disorder among children and adolescents: a systematic review and meta-analysis.

Authors:  Ensiyeh Jenabi; Saied Bashirian; Salman Khazaei; Zohreh Basiri
Journal:  Korean J Pediatr       Date:  2019-06-14

9.  Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?

Authors:  Oscar G Bukstein; L Eugene Arnold; Jeanne M Landgraf; Paul Hodgkins
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-12-10       Impact factor: 3.033

10.  Management of ADHD in children across Europe: patient demographics, physician characteristics and treatment patterns.

Authors:  Paul Hodgkins; Juliana Setyawan; Debanjali Mitra; Keith Davis; Javier Quintero; Moshe Fridman; Monica Shaw; Valerie Harpin
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.